USF Diabetes Center
USF Health

Diabetes Research: Finding a Cure

Type 2 Diabetes Studies

People with Type 2 Diabetes

Study Title

Purpose

Wel-A-U307
Primary Investigator- Henry Rodriguez, MD

To assess the effectiveness and safety of Colesevelam (a drug currently approved by the FDA for only adults) in children ages 10-17 years old as a therapy to help control blood sugar levels and cholesterol.

Novo Nordisk (NN2211-3659)
Primary Investigator- Henry Rodriguez, MD

To assess the effectiveness and safety of Liraglutide (a drug currently approved by the FDA for only adults) in children ages 10-17 years old as a therapy to help control blood sugar levels.

Merck 289
Primary Investigator- Sureka Bollepalli, MD

To assess the effectiveness and safety of MK-0431 A XR (Sitagliptin + XR Metformin) in children ages 10-17 years old as a therapy to help control blood sugar levels. These medications are currently approved by the FDA for only adults)

BMS CV181-058
Primary Investigator- Henry Rodriguez, MD

To assess the effectiveness and safety of Saxagliptin (a drug currently approved by the FDA for only adults) in children ages 10-17 years old as a therapy to help control blood sugar levels.

BMS CV181-147
Primary Investigator- Henry Rodriguez, MD

To assess the effectiveness and safety of Saxagliptin in combination with metformin IR or metformin XR in children ages 10-17 years. (Sitagliptin + XR Metformin are drugs currently approved by the FDA for only adults) old as a therapy to help control blood sugar levels.